BRITISH PHARMACOLOGICAL SOCIETY
To promote and advance pharmacology nationally and internationally (including clinical pharmacology)
Objects
THE OBJECT FOR WHICH THE SOCIETY IS ESTABLISHED IS TO PROMOTE AND ADVANCE PHARMACOLOGY (INCLUDING WITHOUT LIMITATION CLINICAL PHARMACOLOGY).
Financial health, per its FY2025 accounts
The accounts state that total funds increased to £11,068,276, driven largely by a significant donation of £5,147,687. Unrestricted reserves stood at £5,413,438, which the Trustees consider to be 160% of their stated policy target of £2,250,000. The charity reported a net loss on investments of £170,705 but maintained adequate resources to continue in operational existence.
What the accounts disclose
“In the band £120,001 - £130,000” — page 34
“Donations and legacies which totalled £5,147,687”
“a level of £2,250,000 would allow the Society to fulfil is commitments to its members both in terms of operations and activities over a period of one year if the Society’s publications income failed or were severely reduced”
“During the course of the year the Society transacted with BPS Assessment Limited and BPS Trading Services, its wholly-owned subsidiary undertakings. The amounts owing to and from the subsidiary are included in notes 17 and 18.” — page 42
Policies the charity declares
- Bullying and harassment policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/12/2025
- Government income: £67,369 — contracts £67,369 (5); under 1% of the £9,863,328 total gross income on the same return
- Employees paid over £60,000: 8 (£60,001–£70,000: 1; £70,001–£80,000: 4; £90,001–£100,000: 1; £110,001–£120,000: 2)
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 31/12/2024
- Volunteers: 900
- Government income: £67,329 — contracts £47,734 (3), grants £19,595 (1); 1% of the £4,742,376 total gross income on the same return
- Employees paid over £60,000: 6 (£60,001–£70,000: 3; £90,001–£100,000: 1; £110,001–£120,000: 1; £120,001–£130,000: 1)
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 31/12/2023
- Volunteers: 900
- Government income: £100,852 — contracts £100,852 (3); 2% of the £5,346,500 total gross income on the same return
- Employees paid over £60,000: 8 (£60,001–£70,000: 3; £80,001–£90,000: 1; £90,001–£100,000: 2; £110,001–£120,000: 1; £120,001–£130,000: 1)
- Has a trading subsidiary
In the news
- Professor Emma Baker awarded prestigious Zaimis Prize by the British Pharmacological Society
- NPP Trevor Smart receive the Award of Honorary Fellowship of the British Pharmacological Society
- UCC Student Lorna Collins Receives The British Pharmacological Society Undergraduate Pharmacology Prize
- Professor Carl Kirkpatrick name 2024 Fellow of the British Pharmacological Society
- British Pharmacological Society CEO leaves for Royal College of Anaesthetists
- Dr Paul Mitchell named Fellow of the British Pharmacological Society
- Professor Steve Ward elected an Honorary Fellow of the British Pharmacological Society
- British Pharmacological Society Names V. Craig Jordan, DSc, PhD, Recipient of the Sir Henry Wellcome Gold Medal
Corporate structure
- Registered company of the charity Companies House 02877400
- Trading subsidiary: BPS ASSESSMENT LIMITED Companies House 09973409
- Trading subsidiary: BPS TRADING SERVICES LIMITED Companies House 09973456
- Turnover: £73k
- Profit before tax: £21k
- Donated/gift-aided to the charity: £21k
“All profits in the company will be gift aided to the parent entity and no Corporation Tax is expected to arise.”
- Turnover: £454k
- Profit before tax: £62k
- Creditors include £39,357 due to the parent undertaking (British Pharmacological Society).
Funders the charity credits
- Eli Lilly and Company
Company officers (Companies House)
- MAXWELL, Simon Robert Jenkinson, Dr on trustee list
- SHAMSALDEEN, Yousif, Dr on trustee list
- GILES, Heather, Dr on trustee list
- HYLAND, Niall Patrick, Dr on trustee list
- KHAN, Farhan Ahmad, Professor on trustee list
- WAINWRIGHT, Cherry Lindsey, Professor on trustee list
- RITTER, James Michael, Professor on trustee list
- SPEDDING, Michael, Professor on trustee list
- BRIFFA, Edward Ian on trustee list
- POOLE, Michael John
Property (HM Land Registry)
Structured financials (annual return, FY ending 31/12/2025)
Trustees
- Dr Heather Giles
- Dr Niall Patrick Hyland
- Dr Yousif Shamsaldeen
- Edward Briffa
- Professor Cherry Lindsey Wainwright
- Professor Farhan Ahmad Khan
- Professor James Michael Ritter
- Professor Michael Spedding
- Professor Simon Robert Jenkinson Maxwell
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £9.9m | £5.0m |
| 31/12/2024 | £4.7m | £4.3m |
| 31/12/2023 | £5.3m | £5.6m |
| 31/12/2022 | £4.3m | £4.6m |
| 31/12/2021 | £4.5m | £4.2m |
Common questions
Is BRITISH PHARMACOLOGICAL SOCIETY financially healthy?
Per its FY2025 accounts: The accounts state that total funds increased to £11,068,276, driven largely by a significant donation of £5,147,687. Unrestricted reserves stood at £5,413,438, which the Trustees consider to be 160% of their stated policy target of £2,250,000. The charity reported a net loss on investments of £170,705 but maintained adequate resources to continue in operational existence. Its FY2025 accounts were audited by Buzzacott Audit LLP.
What does the highest-paid employee of BRITISH PHARMACOLOGICAL SOCIETY earn?
Per its FY2025 accounts, the highest-paid employee was in the £120,001 - £130,000 band.
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| UK government | 15/02/2024 | £22k | UK Regulatory Science and Innovation Network in Pharmacogenomics |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| BRITISH HEART FOUNDATION | 1 | £1.7m |
| THE MAURICE WOHL CHARITABLE FOUNDATION | 1 | £1.4m |
| THE NUFFIELD FOUNDATION | 1 | £518k |
| THE SINO-BRITISH FELLOWSHIP TRUST | 1 | £214k |
| ROYAL COMMISSION FOR THE EXHIBITION OF 1851 | 1 | £86k |
| THE JAMES WEIR FOUNDATION | 1 | £80k |
| THE BRITISH INSTITUTE OF ARCHAEOLOGY AT ANKARA | 1 | £72k |
| HEART RESEARCH UK | 1 | £60k |
Charities like this
- BRITISH ASSOCIATION FOR PSYCHOPHARMACOLOGY
- THE BRITISH TOXICOLOGY SOCIETY
- BRITISH SOCIETY OF ENDOVASCULAR THERAPY
- THE BRITISH PORPHYRIA ASSOCIATION
- THE BRITISH SOCIETY FOR PARASITOLOGY
- THE BRITISH ACADEMY FOR THE PROMOTION OF HISTORICAL PHILOSOPHICAL AND PHILOLOGICAL STUDIES
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| BRITISH PHARMACOLOGICAL SOCIETY | £9.9m | £120,001 - £130,000 | — | above | — | no doubt |
| BRITISH ASSOCIATION FOR PSYCHOPHARMACOLOGY | £904k | — | 0 | unclear | 0.0% | no doubt |
| THE BRITISH TOXICOLOGY SOCIETY | £283k | — | 0 | unclear | — | no doubt |
| BRITISH SOCIETY OF ENDOVASCULAR THERAPY | £364k | — | 0 | above | — | no doubt |
| THE BRITISH PORPHYRIA ASSOCIATION | £179k | — | 0 | unclear | — | no doubt |
| THE BRITISH SOCIETY FOR PARASITOLOGY | £121k | — | 0 | unclear | — | no doubt |